Cardiosonic ^{For Profit}

Cardiosonic develops pioneering solutions for transluminal high-intensity ultrasound ablation. It has developed a high intensity, non-focused therapeutic ultrasound catheter and control system for remote tissue ablation for the treatment of hypertension by Renal Denervation. The company has tested the TIVUSTM system in extensive bench and animal studies and recently initiated a pilot human clinical trial.